Study to Assess the Bioequivalence Between Ticagrelor Orodispersible Tablets and Ticagrelor Immediate-release Tablets in Japanese Subjects

Clinical trial NCT02436577 · COMPLETED

Trial details

NCT number: NCT02436577
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bioequivalence Healthy Japanese Subjects Pharmacokinetics

Start date: 2015-06-01
Primary completion: 2015-08-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.